Connect your AI

Apyx Medical Corporation APYX Price / book

Price / book at other companies

ArtivionAORT

3.9×+0.4×

AngioDynamicsANGO

2.7×+0.7×

AIR

AirSculpt Technologies, Inc.AIRS

1.8×0.0×

PROCEPT BioRobotics CorporationPRCT

4.1×—

AtriCureATRC

2.9×-0.6×

Pulse Biosciences, Inc.PLSE

22.1×+13.2×

Other financials

Income statement

Revenue$12.5M+32.4%

Gross profit$7.5M-19.2%

Operating income-$5.5M-349%

Net income-$2.1M+48.6%

EPS (diluted)-$0.19-533%

Balance sheet

Cash & equivalents$31.1M+0.4%

Total debt$39.5M+1.4%

Total equity$12.8M+22.1%

Total assets$63.0M+4.8%

Cash flow

Operating cash flow-$572.0K+18.5%

CapEx$60.0K+9.1%

Free cash flow-$632.0K+16.5%

Valuation

Market cap$181.07M+114%

Enterprise value$189.4M+101%

P/S3.2×+1.4×

Profitability

Gross margin61.9%-3.1pp

Operating margin-46%+9.9pp

Net margin-16.2%-6.2pp

FCF margin-16.1%-4.8pp

Returns & leverage

Return on equity-77.8%-22.4pp

Debt / equity3.1×-0.6×

Current ratio5.8×+0.3×

Where this comes from

Calculated from Apyx Medical Corporation’s reported figures.

market cap/total stockholders equity=12×

Based on the most recent quarter.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Apyx Medical Corporation's price / book?: Apyx Medical Corporation (APYX) reported price / book of 12× in Q1 2026.
How has Apyx Medical Corporation's price / book changed year-over-year?: Apyx Medical Corporation's price / book increased by 144.2% year-over-year, from 4.9× to 12×.
What is the long-term trend for Apyx Medical Corporation's price / book?: Over 5 years (2020 to 2025), Apyx Medical Corporation's price / book has grown at a 20.6% compound annual growth rate (CAGR), from 3.9× to 9.9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.